Skip to main content
Division of Cancer Prevention
Division of Cancer Prevention

Search form

Making cancer prevention possible

Main menu

  • Home
  • Major Programs
    • Cancer Prevention Fellowship Program (CPFP)
    • Early Detection Research Network (EDRN)
    • NCI Community Oncology Research Program (NCORP)
    • Alliance of Glycobiologists for Cancer Research
    • Barrett's Esophagus Translational Research Network (BETRNet)
    • Cancer Prevention Clinical Trials Network (CP-CTNet)
    • Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT)
    • Consortium for Imaging and Biomarkers (CIB)
    • HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network
    • Liquid Biopsy Consortium
    • Multi-Cancer Early Detection (MCED)
    • NCI Cervical Cancer ‘Last Mile’ Initiative
    • Pancreatic Cancer Detection Consortium (PCDC)
    • Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)
    • PREVENT Cancer Preclinical Drug Development Program (PREVENT)
    • Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
    • Small Cell Lung Cancer (SCLC) Consortium
    • Supportive Care and Symptom Management
    • Translational and Basic Science Research in Early Lesions (TBEL) Program
    • Translational Liver Cancer (TLC) Consortium
    • US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)
  • Research Groups
    • Biometry
    • Breast and Gynecologic Cancer
    • Cancer Biomarkers
    • Chemopreventive Agent Development
    • Community Oncology and Prevention Trials
    • Early Detection
    • Gastrointestinal and Other Cancers
    • Lung and Upper Aerodigestive Cancer
    • Nutritional Science
    • Prostate and Urologic Cancer
  • Clinical Trials
    • Clinical Trials Search
    • Landmark Trials
    • Clinical Trials Management
    • Why I Joined a Clinical Trial
  • Funding & Grants
    • Funding Opportunities
    • Funded Grants
    • Grantsmanship Resources
  • Resources
    • Publication Search
    • Biorepositories
    • Cancer Data Access System
  • News & Events
    • News
    • Blog
    • Meetings and Events
    • Videos and Webinars
    • Infographics
  • About DCP
    • Scientific Scope
    • Commemoration of the 50th Anniversary of the National Cancer Act
    • Director
    • DCP Leadership
    • History and Timeline
    • Historical Resources
    • Staff Directory

You are here

  1. Home
  2.   »  Home
Established Risk Factors for Developing Female Breast Cancer

Large Studies Evaluating How to Personalize Breast Cancer Screening for All Women

Established Risk Factors for Developing Female Breast Cancer

In the era of personalized medicine, prevention and screening for breast cancer are evolving toward new approaches that assess each woman’s risk and lifestyle factors.

All women do not carry the same risk for the same type of breast cancer. The old one-size-fits-all screening method can miss the most aggressive forms of the disease, or result in overdiagnosis of indolent disease.

Established Risk Factors for Developing Female Breast Cancer
Precision cancer screening and prevention strategies: population risk, biological risk, modality, delivery

How Precision Cancer Prevention Can Promote Health Equity

Precision cancer screening and prevention strategies: population risk, biological risk, modality, delivery

Overall, cancer death rates in the United States have been declining about 2% per year, current SEER data from 2014 through 2018 show. However, these improvements have not been experienced equally by everyone, which is one of the reasons that April is Minority Cancer Awareness Month, when we call attention to these disparities.

Precision cancer screening and prevention strategies: population risk, biological risk, modality, delivery

MISSION STATEMENT

The Division of Cancer Prevention furthers the mission of the National Cancer Institute by leading, supporting, and promoting rigorous, innovative research and training to prevent cancer and its consequences to improve the health of all people.

Read more about Our Research

 

Latest News

Read All News

ULACNet Update - April 2022

Welcome to ULACNet Update, where we will share programmatic and research updates for the US-Latin American-Caribbean HIV/HPV-Cancer...
April 28 | DCP News

Screening for Many Cancers with One Test: Uncertainty Abounds

One of the exciting areas of cancer prevention research is the development of noninvasive tests that may have the potential to easily and accurately...
April 21|NCI Cancer Currents Blog

Can Cancer Blood Tests Live Up to Promise of Saving Lives?

Joyce Ares had just turned 74 and was feeling fine when she agreed to give a blood sample for research. So she was surprised when the screening test...
April 11|AP News

DCP/PREVENT-funded Project Presentations at the 2022 AACR Annual Meeting

April 8-13, 2022 DCP/PREVENT-funded Project Presentations Session OPO.IM01.01 - Tumor Immunobiology 5631 - Immunomodulatory...
April 1 | DCP News

Meetings and Events

Review All Our Meetings and Events

Helping to End Addiction Long-Term (HEAL): The NCI Perspective

Date(s):
  • Monday, May 23, 2022 - 11:00am - 12:00pm EDT

Location: Virtual via WebEx

Alcohol, Cancer and the Potential Impact of the COVID-19 Pandemic on Future Alcohol-attributable Cancer Rates

Date(s):
  • Tuesday, May 31, 2022 - 11:00am - 12:00pm EDT

Location: Virtual via WebEx

NIH Pathways to Prevention Workshop: Nutrition as Prevention for Improved Cancer Health Outcomes

Date(s):
  • Tuesday, July 26, 2022 - 12:00pm EDT - Thursday, July 28, 2022 - 5:00pm EDT

Location: Virtual via WebEx

Twitter Feeds

@NCIprevention

Tweets by NCIprevention

@NCISymptomMgmt

Tweets by NCISymptomMgmt

@NCICastle

Tweets by NCICastle

Follow us at:

@NCIPrevention

@NCISymptomMgmt

@NCICastle

The National Cancer Institute

Policies

DCP Home

Contact DCP

Policies

Disclaimer Policy

Accessibility

FOIA

HHS Vulnerability Disclosure

NCI's PDQ® Evidence-based Summaries

Cancer Prevention

Screening/Detection/Testing for Cancer

Supportive and Palliative Care

General Information

Cancer Prevention, Specific Cancers, Clinical Trials

Cancer Screening Topics For People Who Have No Symptoms

Managing The Side Effects of Cancer and Its Treatment

Coping With Cancer

US Preventive Services Task Force Recommendations About Cancer

NIH COVID-19 Resources

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®